25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ISU Abxis Co. Ltd
Buy, Hold or Sell?

Let's analyze Abxis together

I guess you are interested in ISU Abxis Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ISU Abxis Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ISU Abxis Co. Ltd

I send you an email if I find something interesting about ISU Abxis Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Abxis (30 sec.)










1.2. What can you expect buying and holding a share of Abxis? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,024.78
Expected worth in 1 year
₩2,251.66
How sure are you?
41.4%

+ What do you gain per year?

Total Gains per Share
₩226.88
Return On Investment
4.6%

For what price can you sell your share?

Current Price per Share
₩4,970.00
Expected price per share
₩4,895 - ₩5,670
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Abxis (5 min.)




Live pricePrice per Share (EOD)
₩4,970.00

2.2. Growth of Abxis (5 min.)




Is Abxis growing?

Current yearPrevious yearGrowGrow %
How rich?$49.2m$43.2m$3.8m8.2%

How much money is Abxis making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$828.5k-$216.2k-20.7%
Net Profit Margin-8.6%-15.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Abxis (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Abxis?

Welcome investor! Abxis's management wants to use your money to grow the business. In return you get a share of Abxis.

First you should know what it really means to hold a share of Abxis. And how you can make/lose money.

Speculation

The Price per Share of Abxis is ₩4,970. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abxis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abxis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,024.78. Based on the TTM, the Book Value Change Per Share is ₩56.72 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-37.87 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abxis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.040.0%-0.030.0%-0.020.0%-0.060.0%-0.060.0%
Usd Book Value Change Per Share0.170.0%0.040.0%-0.030.0%-0.020.0%0.050.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.170.0%0.040.0%-0.030.0%-0.020.0%0.050.0%
Usd Price Per Share4.53-4.60-4.36-5.60-5.69-
Price to Earnings Ratio27.48-82.09--188.89--37.57-7.10-
Price-to-Total Gains Ratio26.25-304.43--744.13--112.16--88.71-
Price to Book Ratio3.20-3.40-3.36-4.08-4.07-
Price-to-Total Gains Ratio26.25-304.43--744.13--112.16--88.71-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.479
Number of shares287
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.04-0.02
Usd Total Gains Per Share0.04-0.02
Gains per Quarter (287 shares)11.39-4.74
Gains per Year (287 shares)45.58-18.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1046360-19-29
2091820-38-48
301371280-57-67
401821740-76-86
502282200-95-105
602732660-114-124
703193120-133-143
803653580-152-162
904104040-171-181
1004564500-190-200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%5.07.00.041.7%5.015.00.025.0%6.023.00.020.7%6.023.00.020.7%
Book Value Change Per Share3.01.00.075.0%5.07.00.041.7%7.013.00.035.0%12.017.00.041.4%12.017.00.041.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share3.01.00.075.0%5.07.00.041.7%7.013.00.035.0%12.017.00.041.4%12.017.00.041.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ISU Abxis Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--246.50356.719+335%-37.873+115%-23.616+110%69.820+253%
Book Value Per Share--2024.7801959.271+3%1862.750+9%1960.665+3%2008.492+1%
Current Ratio--1.3541.511-10%3.296-59%7.871-83%7.434-82%
Debt To Asset Ratio--0.4990.564-11%0.562-11%0.505-1%0.412+21%
Debt To Equity Ratio--0.9971.319-24%1.286-22%1.085-8%0.832+20%
Dividend Per Share----0%-0%-0%-0%
Eps--58.866-42.586+172%-35.669+161%-86.017+246%-88.891+251%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap132327741000.000-70%224961977640.000225539275697.5000%206645077425.000+9%249369296904.500-10%244773814295.475-8%
Net Profit Margin--0.143-0.086+160%-0.159+211%-0.376+364%-0.458+421%
Operating Margin----0%-0.0040%-0.2560%-0.3640%
Operating Ratio--0.4030.928-57%1.362-70%1.018-60%1.356-70%
Pb Ratio2.455-30%3.1953.400-6%3.355-5%4.083-22%4.070-21%
Pe Ratio21.107-30%27.47882.092-67%-188.888+787%-37.569+237%7.104+287%
Price Per Share4970.000-30%6470.0006575.000-2%6227.500+4%7998.000-19%8123.794-20%
Price To Free Cash Flow Ratio----0.4030%-14.2780%-21.6600%-21.5730%
Price To Total Gains Ratio20.162-30%26.247304.433-91%-744.132+2935%-112.163+527%-88.714+438%
Quick Ratio---0.445-100%2.979-100%6.390-100%4.943-100%
Return On Assets--0.015-0.016+207%-0.009+159%-0.026+278%-0.029+297%
Return On Equity--0.029-0.032+209%-0.020+168%-0.048+264%-0.046+259%
Total Gains Per Share--246.50356.719+335%-37.873+115%-23.616+110%69.820+253%
Usd Book Value--49281133.30047123651.367+5%43267720.290+14%42673342.909+15%42112130.673+17%
Usd Book Value Change Per Share--0.1730.040+335%-0.027+115%-0.017+110%0.049+253%
Usd Book Value Per Share--1.4171.371+3%1.304+9%1.372+3%1.406+1%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.041-0.030+172%-0.025+161%-0.060+246%-0.062+251%
Usd Free Cash Flow----2034805.5490%-3070414.7930%-2123163.1440%-2286596.2420%
Usd Market Cap92629418.700-70%157473384.348157877492.9880%144651554.198+9%174558507.833-10%171341670.007-8%
Usd Price Per Share3.479-30%4.5294.603-2%4.359+4%5.599-19%5.687-20%
Usd Profit--1432748.100-1044720.609+173%-828508.576+158%-1704202.580+219%-1751370.358+222%
Usd Revenue--10039362.90010859521.579-8%8441536.794+19%6690087.105+50%5634460.663+78%
Usd Total Gains Per Share--0.1730.040+335%-0.027+115%-0.017+110%0.049+253%
 EOD+3 -4MRQTTM+19 -7YOY+22 -45Y+20 -610Y+18 -8

3.3 Fundamental Score

Let's check the fundamental score of ISU Abxis Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.107
Price to Book Ratio (EOD)Between0-12.455
Net Profit Margin (MRQ)Greater than00.143
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.354
Debt to Asset Ratio (MRQ)Less than10.499
Debt to Equity Ratio (MRQ)Less than10.997
Return on Equity (MRQ)Greater than0.150.029
Return on Assets (MRQ)Greater than0.050.015
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of ISU Abxis Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.486
Ma 20Greater thanMa 505,513.000
Ma 50Greater thanMa 1006,051.200
Ma 100Greater thanMa 2006,315.300
OpenGreater thanClose4,975.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About ISU Abxis Co. Ltd

ISU Abxis Co., Ltd., a biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide. The company offers Abcertin, an imiglucerase for injection that is used as long-term enzyme replacement therapy in patients with a confirmed diagnosis of Type 1 Gaucher disease; Fabagal, an agalsidase beta for injection, which is used as a long term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease; and Clotinab, an abciximab that is used as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications. It is also developing ISU104, a human antibody for the treatment of refractory cancer; ISU304, a modified recombinant factor IX protein for the treatment of Hemophilia B patients; and ISU305, an antibody biosimilar for paroxysmal nocturnal hemoglobinuria therapy. ISU Abxis Co., Ltd. is headquartered in Seongnam, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 20:40:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Abxis earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Abxis to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 14.3% means that ₩0.14 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ISU Abxis Co. Ltd:

  • The MRQ is 14.3%. The company is making a huge profit. +2
  • The TTM is -8.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ14.3%TTM-8.6%+22.8%
TTM-8.6%YOY-15.9%+7.3%
TTM-8.6%5Y-37.6%+29.1%
5Y-37.6%10Y-45.8%+8.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%9.8%+4.5%
TTM-8.6%9.5%-18.1%
YOY-15.9%9.9%-25.8%
5Y-37.6%12.9%-50.5%
10Y-45.8%12.6%-58.4%
4.3.1.2. Return on Assets

Shows how efficient Abxis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abxis to the Pharmaceuticals industry mean.
  • 1.5% Return on Assets means that Abxis generated ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ISU Abxis Co. Ltd:

  • The MRQ is 1.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.5%TTM-1.6%+3.0%
TTM-1.6%YOY-0.9%-0.7%
TTM-1.6%5Y-2.6%+1.0%
5Y-2.6%10Y-2.9%+0.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%3.6%-2.1%
TTM-1.6%3.5%-5.1%
YOY-0.9%5.3%-6.2%
5Y-2.6%5.9%-8.5%
10Y-2.9%4.9%-7.8%
4.3.1.3. Return on Equity

Shows how efficient Abxis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abxis to the Pharmaceuticals industry mean.
  • 2.9% Return on Equity means Abxis generated ₩0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ISU Abxis Co. Ltd:

  • The MRQ is 2.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -3.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.9%TTM-3.2%+6.1%
TTM-3.2%YOY-2.0%-1.2%
TTM-3.2%5Y-4.8%+1.6%
5Y-4.8%10Y-4.6%-0.1%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9%4.6%-1.7%
TTM-3.2%4.6%-7.8%
YOY-2.0%8.2%-10.2%
5Y-4.8%9.1%-13.9%
10Y-4.6%10.3%-14.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ISU Abxis Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Abxis is operating .

  • Measures how much profit Abxis makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abxis to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ISU Abxis Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.4%+0.4%
TTM-5Y-25.6%+25.6%
5Y-25.6%10Y-36.4%+10.8%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY-0.4%12.4%-12.8%
5Y-25.6%8.6%-34.2%
10Y-36.4%12.1%-48.5%
4.3.2.2. Operating Ratio

Measures how efficient Abxis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 0.40 means that the operating costs are ₩0.40 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of ISU Abxis Co. Ltd:

  • The MRQ is 0.403. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.928. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.403TTM0.928-0.525
TTM0.928YOY1.362-0.434
TTM0.9285Y1.018-0.090
5Y1.01810Y1.356-0.338
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4031.225-0.822
TTM0.9281.220-0.292
YOY1.3621.311+0.051
5Y1.0181.249-0.231
10Y1.3561.240+0.116
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ISU Abxis Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Abxis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 1.35 means the company has ₩1.35 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of ISU Abxis Co. Ltd:

  • The MRQ is 1.354. The company is just able to pay all its short-term debts.
  • The TTM is 1.511. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.354TTM1.511-0.157
TTM1.511YOY3.296-1.785
TTM1.5115Y7.871-6.360
5Y7.87110Y7.434+0.438
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3542.213-0.859
TTM1.5112.234-0.723
YOY3.2962.028+1.268
5Y7.8712.199+5.672
10Y7.4341.995+5.439
4.4.3.2. Quick Ratio

Measures if Abxis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abxis to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ISU Abxis Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.445-0.445
TTM0.445YOY2.979-2.534
TTM0.4455Y6.390-5.945
5Y6.39010Y4.943+1.447
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM0.4450.973-0.528
YOY2.9791.515+1.464
5Y6.3901.591+4.799
10Y4.9431.399+3.544
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ISU Abxis Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Abxis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abxis to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.50 means that Abxis assets are financed with 49.9% credit (debt) and the remaining percentage (100% - 49.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ISU Abxis Co. Ltd:

  • The MRQ is 0.499. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.564. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.499TTM0.564-0.065
TTM0.564YOY0.562+0.003
TTM0.5645Y0.505+0.059
5Y0.50510Y0.412+0.093
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4990.345+0.154
TTM0.5640.339+0.225
YOY0.5620.333+0.229
5Y0.5050.315+0.190
10Y0.4120.339+0.073
4.5.4.2. Debt to Equity Ratio

Measures if Abxis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abxis to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 99.7% means that company has ₩1.00 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ISU Abxis Co. Ltd:

  • The MRQ is 0.997. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.319. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.997TTM1.319-0.322
TTM1.319YOY1.286+0.034
TTM1.3195Y1.085+0.235
5Y1.08510Y0.832+0.253
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9970.547+0.450
TTM1.3190.547+0.772
YOY1.2860.499+0.787
5Y1.0850.476+0.609
10Y0.8320.548+0.284
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Abxis generates.

  • Above 15 is considered overpriced but always compare Abxis to the Pharmaceuticals industry mean.
  • A PE ratio of 27.48 means the investor is paying ₩27.48 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ISU Abxis Co. Ltd:

  • The EOD is 21.107. Based on the earnings, the company is fair priced.
  • The MRQ is 27.478. Based on the earnings, the company is overpriced. -1
  • The TTM is 82.092. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD21.107MRQ27.478-6.370
MRQ27.478TTM82.092-54.614
TTM82.092YOY-188.888+270.980
TTM82.0925Y-37.569+119.661
5Y-37.56910Y7.104-44.673
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD21.10727.863-6.756
MRQ27.47829.844-2.366
TTM82.09227.532+54.560
YOY-188.88823.102-211.990
5Y-37.56927.577-65.146
10Y7.10429.248-22.144
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ISU Abxis Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.403+0.403
TTM-0.403YOY-14.278+13.876
TTM-0.4035Y-21.660+21.257
5Y-21.66010Y-21.573-0.087
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM-0.40329.447-29.850
YOY-14.27826.360-40.638
5Y-21.66031.734-53.394
10Y-21.57334.357-55.930
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Abxis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 3.20 means the investor is paying ₩3.20 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of ISU Abxis Co. Ltd:

  • The EOD is 2.455. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.195. Based on the equity, the company is fair priced.
  • The TTM is 3.400. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.455MRQ3.195-0.741
MRQ3.195TTM3.400-0.205
TTM3.400YOY3.355+0.045
TTM3.4005Y4.083-0.683
5Y4.08310Y4.070+0.014
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD2.4554.659-2.204
MRQ3.1953.381-0.186
TTM3.4003.209+0.191
YOY3.3552.597+0.758
5Y4.0833.278+0.805
10Y4.0704.179-0.109
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets140,585,690
Total Liabilities70,184,071
Total Stockholder Equity70,401,619
 As reported
Total Liabilities 70,184,071
Total Stockholder Equity+ 70,401,619
Total Assets = 140,585,690

Assets

Total Assets140,585,690
Total Current Assets87,299,181
Long-term Assets53,286,509
Total Current Assets
Total Current Assets  (as reported)87,299,181
Total Current Assets  (calculated)0
+/- 87,299,181
Long-term Assets
Long-term Assets  (as reported)53,286,509
Long-term Assets  (calculated)0
+/- 53,286,509

Liabilities & Shareholders' Equity

Total Current Liabilities64,479,133
Long-term Liabilities5,704,938
Total Stockholder Equity70,401,619
Total Current Liabilities
Total Current Liabilities  (as reported)64,479,133
Total Current Liabilities  (calculated)0
+/- 64,479,133
Long-term Liabilities
Long-term Liabilities  (as reported)5,704,938
Long-term Liabilities  (calculated)0
+/- 5,704,938
Total Stockholder Equity
Total Stockholder Equity (as reported)70,401,619
Total Stockholder Equity (calculated)0
+/- 70,401,619
Other
Common Stock Shares Outstanding 34,770
Net Working Capital 22,820,048



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
57,264,416
57,434,271
77,766,701
79,729,066
83,039,867
72,915,764
69,840,016
65,055,613
103,399,260
99,798,047
92,763,104
88,934,695
84,538,491
85,688,067
82,747,105
78,245,271
157,910,844
155,389,898
151,090,755
147,028,285
156,149,905
153,994,829
137,270,521
134,986,092
138,694,802
140,596,030
206,738,432
139,333,350
140,585,690
140,585,690139,333,350206,738,432140,596,030138,694,802134,986,092137,270,521153,994,829156,149,905147,028,285151,090,755155,389,898157,910,84478,245,27182,747,10585,688,06784,538,49188,934,69592,763,10499,798,047103,399,26065,055,61369,840,01672,915,76483,039,86779,729,06677,766,70157,434,27157,264,416
   > Total Current Assets 
31,104,120
31,106,680
53,126,266
55,265,097
56,564,925
45,333,298
40,007,695
35,647,745
73,336,119
67,294,043
60,093,523
56,169,688
50,910,562
49,940,385
47,097,994
44,605,861
125,185,432
72,527,103
68,816,702
65,634,322
70,910,975
65,591,716
77,773,620
74,941,403
75,101,177
96,051,708
159,049,934
90,027,960
87,299,181
87,299,18190,027,960159,049,93496,051,70875,101,17774,941,40377,773,62065,591,71670,910,97565,634,32268,816,70272,527,103125,185,43244,605,86147,097,99449,940,38550,910,56256,169,68860,093,52367,294,04373,336,11935,647,74540,007,69545,333,29856,564,92555,265,09753,126,26631,106,68031,104,120
       Cash And Cash Equivalents 
7,628,586
4,377,649
16,774,367
18,374,376
20,575,370
7,110,547
12,117,817
7,693,109
16,984,040
11,979,931
10,123,392
5,701,361
8,083,038
8,326,141
11,462,616
6,308,988
89,776,833
16,340,229
1,611
2,811
5,691
7,138
1,567
1,287
2,295
33,576,751
96,329,906
20,828,153
0
020,828,15396,329,90633,576,7512,2951,2871,5677,1385,6912,8111,61116,340,22989,776,8336,308,98811,462,6168,326,1418,083,0385,701,36110,123,39211,979,93116,984,0407,693,10912,117,8177,110,54720,575,37018,374,37616,774,3674,377,6497,628,586
       Short-term Investments 
1,070,300
1,013,800
13,012,800
13,000,000
9,504,000
9,504,000
1,004,000
1,004,000
26,000,000
26,000,000
21,345,197
0
0
0
6,004,022
9,004,022
4,004,000
25,004,000
25,283,000
15,283,000
15,283,000
4,862,000
34,862,000
31,862,000
31,548,000
23,008,000
23,008,000
21,460,000
0
021,460,00023,008,00023,008,00031,548,00031,862,00034,862,0004,862,00015,283,00015,283,00025,283,00025,004,0004,004,0009,004,0226,004,02200021,345,19726,000,00026,000,0001,004,0001,004,0009,504,0009,504,00013,000,00013,012,8001,013,8001,070,300
       Net Receivables 
3,363,509
6,172,592
3,776,595
2,519,938
4,115,964
4,336,799
4,470,788
3,415,392
4,760,819
4,918,071
7,399,458
6,084,327
7,275,340
5,545,961
7,328,294
5,909,904
7,097,626
8,784,563
10,462,128
9,022,868
9,961,050
16,393,294
13,280,569
8,010,131
18,821,338
22,250,369
17,898,796
23,511,592
0
023,511,59217,898,79622,250,36918,821,3388,010,13113,280,56916,393,2949,961,0509,022,86810,462,1288,784,5637,097,6265,909,9047,328,2945,545,9617,275,3406,084,3277,399,4584,918,0714,760,8193,415,3924,470,7884,336,7994,115,9642,519,9383,776,5956,172,5923,363,509
       Inventory 
15,381,895
15,918,575
16,468,385
18,236,721
19,677,586
21,478,291
19,144,110
20,165,377
21,524,949
22,103,643
19,139,158
21,014,282
22,159,739
23,033,904
20,395,748
21,269,114
22,043,518
20,017,167
18,083,162
17,508,027
16,974,746
12,058,103
8,021,694
12,845,986
13,275,743
15,209,316
20,121,743
22,470,818
0
022,470,81820,121,74315,209,31613,275,74312,845,9868,021,69412,058,10316,974,74617,508,02718,083,16220,017,16722,043,51821,269,11420,395,74823,033,90422,159,73921,014,28219,139,15822,103,64321,524,94920,165,37719,144,11021,478,29119,677,58618,236,72116,468,38515,918,57515,381,895
       Other Current Assets 
339,631
396,976
49,125
171,042
62,124
81,065
77,916
75,720
37,064
41,380
151,077
150,036
182,181
168,280
84,687
357,044
560,506
746,043
115,255
260,496
6,369,045
6,381,521
20,000
0
0
0
0
0
0
00000020,0006,381,5216,369,045260,496115,255746,043560,506357,04484,687168,280182,181150,036151,07741,38037,06475,72077,91681,06562,124171,04249,125396,976339,631
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
59,496,901
60,044,689
63,593,624
44,544,322
47,688,499
49,305,390
53,286,509
53,286,50949,305,39047,688,49944,544,32263,593,62460,044,68959,496,9010000000000000000000000
       Property Plant Equipment 
11,302,663
11,204,428
12,604,431
13,413,169
15,582,787
15,966,325
17,714,112
17,592,047
17,815,022
17,910,928
17,715,252
17,042,418
16,314,138
18,084,543
18,007,190
17,332,652
16,737,831
16,629,403
16,237,770
15,890,050
16,180,855
16,506,361
15,914,311
15,469,186
16,199,170
16,477,450
16,879,120
18,202,860
0
018,202,86016,879,12016,477,45016,199,17015,469,18615,914,31116,506,36116,180,85515,890,05016,237,77016,629,40316,737,83117,332,65218,007,19018,084,54316,314,13817,042,41817,715,25217,910,92817,815,02217,592,04717,714,11215,966,32515,582,78713,413,16912,604,43111,204,42811,302,663
       Long Term Investments 
0
341,197
341,197
341,197
341,197
341,197
341,197
0
341,197
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000341,1970341,197341,197341,197341,197341,197341,1970
       Intangible Assets 
513,626
618,905
766,902
750,789
737,329
721,533
760,665
724,718
786,841
12,122,210
12,837,237
13,639,657
15,308,752
16,017,206
16,073,342
15,630,018
15,301,970
15,153,315
14,922,556
14,408,912
16,313,824
18,753,251
20,520,079
21,097,769
21,171,716
22,904,884
25,780,717
26,074,617
0
026,074,61725,780,71722,904,88421,171,71621,097,76920,520,07918,753,25116,313,82414,408,91214,922,55615,153,31515,301,97015,630,01816,073,34216,017,20615,308,75213,639,65712,837,23712,122,210786,841724,718760,665721,533737,329750,789766,902618,905513,626
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000
> Total Liabilities 
13,703,193
14,654,157
15,714,990
13,903,430
17,798,474
9,485,849
10,105,681
8,759,160
36,912,994
37,094,590
37,580,266
38,310,060
37,740,556
33,876,461
39,172,863
18,689,374
91,640,963
92,436,869
79,140,557
80,421,870
91,463,793
90,552,657
72,859,650
75,254,244
79,035,577
80,738,045
129,550,750
77,502,629
70,184,071
70,184,07177,502,629129,550,75080,738,04579,035,57775,254,24472,859,65090,552,65791,463,79380,421,87079,140,55792,436,86991,640,96318,689,37439,172,86333,876,46137,740,55638,310,06037,580,26637,094,59036,912,9948,759,16010,105,6819,485,84917,798,47413,903,43015,714,99014,654,15713,703,193
   > Total Current Liabilities 
8,229,185
8,298,498
10,499,415
9,212,370
13,264,875
5,137,476
6,017,543
5,029,175
5,757,079
5,121,249
5,154,902
4,894,586
3,604,207
5,196,465
6,751,167
5,685,453
6,166,556
6,203,328
5,836,445
5,677,531
8,840,595
6,566,844
68,595,073
71,063,997
74,409,572
76,135,230
72,969,925
72,059,345
64,479,133
64,479,13372,059,34572,969,92576,135,23074,409,57271,063,99768,595,0736,566,8448,840,5955,677,5315,836,4456,203,3286,166,5565,685,4536,751,1675,196,4653,604,2074,894,5865,154,9025,121,2495,757,0795,029,1756,017,5435,137,47613,264,8759,212,37010,499,4158,298,4988,229,185
       Short-term Debt 
7,998,599
4,518,959
5,846,324
5,975,036
6,110,575
1,200,000
1,200,000
1,200,000
1,200,000
900,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000900,0001,200,0001,200,0001,200,0001,200,0006,110,5755,975,0365,846,3244,518,9597,998,599
       Short Long Term Debt 
7,998,599
4,518,959
5,846,324
5,975,036
6,110,575
1,200,000
1,200,000
1,200,000
1,200,000
900,000
0
0
0
0
0
0
0
0
0
0
0
0
30,440,238
32,615,382
34,945,954
37,443,059
40,118,598
30,813,043
0
030,813,04340,118,59837,443,05934,945,95432,615,38230,440,238000000000000900,0001,200,0001,200,0001,200,0001,200,0006,110,5755,975,0365,846,3244,518,9597,998,599
       Accounts payable 
991,700
938,227
1,747,753
1,334,219
3,571,410
930,887
1,803,883
1,229,330
1,553,585
1,528,433
1,514,577
1,716,958
1,021,525
886,688
1,279,869
1,190,535
845,926
889,735
1,219,640
1,428,307
1,683,377
774,565
1,862,633
2,247,596
3,517,738
2,779,191
4,948,715
3,054,688
0
03,054,6884,948,7152,779,1913,517,7382,247,5961,862,633774,5651,683,3771,428,3071,219,640889,735845,9261,190,5351,279,869886,6881,021,5251,716,9581,514,5771,528,4331,553,5851,229,3301,803,883930,8873,571,4101,334,2191,747,753938,227991,700
       Other Current Liabilities 
1,506,551
2,207,788
2,742,056
1,740,690
3,406,630
2,839,412
2,835,960
2,422,320
2,434,487
2,491,949
3,335,449
2,886,911
2,262,618
3,464,501
4,539,731
3,482,511
4,375,269
4,398,300
3,714,222
3,319,612
6,236,038
4,862,195
14,454
0
0
-1
28,259
81
0
08128,259-10014,4544,862,1956,236,0383,319,6123,714,2224,398,3004,375,2693,482,5114,539,7313,464,5012,262,6182,886,9113,335,4492,491,9492,434,4872,422,3202,835,9602,839,4123,406,6301,740,6902,742,0562,207,7881,506,551
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,264,577
4,190,247
4,626,005
4,602,815
56,580,825
5,443,284
5,704,938
5,704,9385,443,28456,580,8254,602,8154,626,0054,190,2474,264,5770000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
24,757,068
24,523,818
25,327,494
26,026,028
21,440,789
25,020,287
8,123,239
21,555,301
22,481,579
24,021,231
25,745,961
27,514,297
28,761,383
367,962
349,650
653,643
0
0
0
0
0000653,643349,650367,96228,761,38327,514,29725,745,96124,021,23122,481,57921,555,3018,123,23925,020,28721,440,78926,026,02825,327,49424,523,81824,757,068000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,131,300
1,116,565
1,472,097
750,803
700,170
749,513
0
0749,513700,170750,8031,472,0971,116,5651,131,3000000000000000000000000
       Other Liabilities 
3,074,008
3,055,659
3,415,576
3,191,060
3,333,599
3,448,373
3,488,138
3,429,985
7,069,537
7,216,273
7,901,546
8,087,980
8,110,321
7,239,207
7,401,410
4,880,682
63,919,107
63,751,962
49,282,881
48,998,378
55,108,901
55,224,430
0
0
0
0
0
0
0
000000055,224,43055,108,90148,998,37849,282,88163,751,96263,919,1074,880,6827,401,4107,239,2078,110,3218,087,9807,901,5467,216,2737,069,5373,429,9853,488,1383,448,3733,333,5993,191,0603,415,5763,055,6593,074,008
> Total Stockholder Equity
43,561,223
42,780,114
62,051,710
65,825,635
65,241,392
63,429,915
59,734,335
56,296,453
66,486,265
62,703,457
55,182,838
50,624,635
46,797,935
51,811,606
43,574,242
59,555,897
66,269,881
62,953,030
71,950,198
66,606,415
64,686,112
63,442,172
64,410,871
59,731,848
59,659,225
59,857,985
77,187,683
61,830,721
70,401,619
70,401,61961,830,72177,187,68359,857,98559,659,22559,731,84864,410,87163,442,17264,686,11266,606,41571,950,19862,953,03066,269,88159,555,89743,574,24251,811,60646,797,93550,624,63555,182,83862,703,45766,486,26556,296,45359,734,33563,429,91565,241,39265,825,63562,051,71042,780,11443,561,223
   Common Stock
9,880,132
9,880,132
12,480,132
13,026,979
13,312,646
13,312,646
13,312,646
13,312,646
13,312,646
13,312,646
13,312,646
13,312,646
13,312,646
14,132,318
14,132,318
15,935,597
16,591,334
16,591,334
16,591,334
16,591,334
16,591,334
16,591,334
16,591,334
16,591,334
16,591,334
0
0
0
0
000016,591,33416,591,33416,591,33416,591,33416,591,33416,591,33416,591,33416,591,33416,591,33415,935,59714,132,31814,132,31813,312,64613,312,64613,312,64613,312,64613,312,64613,312,64613,312,64613,312,64613,312,64613,026,97912,480,1329,880,1329,880,132
   Retained Earnings Total Equity00000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
126,802,509
111,765,239
127,543,656
127,543,656
134,270,124
122,642,072
153,011,509
159,919,902
159,919,902
157,763,127
159,919,902
157,763,127
159,919,902
159,919,902
159,919,902
157,763,127
0
0
0
0
0000157,763,127159,919,902159,919,902159,919,902157,763,127159,919,902157,763,127159,919,902159,919,902153,011,509122,642,072134,270,124127,543,656127,543,656111,765,239126,802,509000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
-1
0
0
867,435
867,434
867,435
867,435
16,645,852
867,435
16,645,852
867,435
13,240,442
867,435
3,024,210
3,024,210
3,024,210
3,024,210
3,024,210
3,024,210
0
0
2,156,775
0
0
0
0
00002,156,775003,024,2103,024,2103,024,2103,024,2103,024,2103,024,210867,43513,240,442867,43516,645,852867,43516,645,852867,435867,435867,434867,43500-1000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue54,305,558
Cost of Revenue-18,923,889
Gross Profit35,381,66835,381,668
 
Operating Income (+$)
Gross Profit35,381,668
Operating Expense-50,419,472
Operating Income3,886,085-15,037,804
 
Operating Expense (+$)
Research Development15,209,534
Selling General Administrative11,306,129
Selling And Marketing Expenses0
Operating Expense50,419,47226,515,663
 
Net Interest Income (+$)
Interest Income1,381,644
Interest Expense-9,883,855
Other Finance Cost-0
Net Interest Income-8,502,211
 
Pretax Income (+$)
Operating Income3,886,085
Net Interest Income-8,502,211
Other Non-Operating Income Expenses0
Income Before Tax (EBT)3,711,6623,886,085
EBIT - interestExpense = -9,883,855
3,610,667
13,494,522
Interest Expense9,883,855
Earnings Before Interest and Taxes (EBIT)013,595,517
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax3,711,662
Tax Provision-100,995
Net Income From Continuing Ops3,610,6673,610,667
Net Income3,610,667
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net08,502,211
 

Technical Analysis of Abxis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Abxis. The general trend of Abxis is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Abxis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ISU Abxis Co. Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5,250 < 5,550 < 5,670.

The bearish price targets are: 4,895.

Tweet this
ISU Abxis Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ISU Abxis Co. Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ISU Abxis Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ISU Abxis Co. Ltd. The current macd is -355.90461814.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Abxis price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Abxis. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Abxis price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ISU Abxis Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartISU Abxis Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ISU Abxis Co. Ltd. The current adx is 38.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Abxis shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
ISU Abxis Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ISU Abxis Co. Ltd. The current sar is 5,656.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ISU Abxis Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ISU Abxis Co. Ltd. The current rsi is 26.49. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
ISU Abxis Co. Ltd Daily Relative Strength Index (RSI) ChartISU Abxis Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ISU Abxis Co. Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Abxis price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
ISU Abxis Co. Ltd Daily Stochastic Oscillator ChartISU Abxis Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ISU Abxis Co. Ltd. The current cci is -82.08215425.

ISU Abxis Co. Ltd Daily Commodity Channel Index (CCI) ChartISU Abxis Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ISU Abxis Co. Ltd. The current cmo is -51.05562068.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ISU Abxis Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartISU Abxis Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ISU Abxis Co. Ltd. The current willr is -95.2681388.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ISU Abxis Co. Ltd Daily Williams %R ChartISU Abxis Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ISU Abxis Co. Ltd.

ISU Abxis Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ISU Abxis Co. Ltd. The current atr is 223.37.

ISU Abxis Co. Ltd Daily Average True Range (ATR) ChartISU Abxis Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ISU Abxis Co. Ltd. The current obv is 29,746,512.

ISU Abxis Co. Ltd Daily On-Balance Volume (OBV) ChartISU Abxis Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ISU Abxis Co. Ltd. The current mfi is 34.10.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
ISU Abxis Co. Ltd Daily Money Flow Index (MFI) ChartISU Abxis Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ISU Abxis Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

ISU Abxis Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ISU Abxis Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.486
Ma 20Greater thanMa 505,513.000
Ma 50Greater thanMa 1006,051.200
Ma 100Greater thanMa 2006,315.300
OpenGreater thanClose4,975.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Abxis with someone you think should read this too:
  • Are you bullish or bearish on Abxis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Abxis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ISU Abxis Co. Ltd

I send you an email if I find something interesting about ISU Abxis Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about ISU Abxis Co. Ltd.

Receive notifications about ISU Abxis Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.